A Massachusetts federal judge issued a nationwide injunction blocking the NIH’s plan to reduce research funding, potentially saving billions for universities and research institutions. The ruling, prompted by a coalition of plaintiffs, prevents NIH’s 15% cap on indirect costs, which would have disrupted critical clinical trials and research. The decision signals a potential victory for the plaintiffs as the case progresses, amid ongoing concerns over NIH’s future leadership and funding policies, as reported by Forbes.
A Massachusetts federal judge issued a nationwide injunction blocking the NIH’s plan to reduce research funding, potentially saving billions for universities and research institutions. The ruling, prompted by a coalition of plaintiffs, prevents NIH’s 15% cap on indirect costs, which would have disrupted critical clinical trials and research. The decision signals a potential victory for the plaintiffs as the case progresses, amid ongoing concerns over NIH’s future leadership and funding policies, as reported by Forbes. A Massachusetts federal judge issued a nationwide injunction blocking the NIH’s plan to reduce research funding, potentially saving billions for universities and research institutions. The ruling, prompted by a coalition of plaintiffs, prevents NIH’s 15% cap on indirect costs, which would have disrupted critical clinical trials and research. The decision signals a potential victory for the plaintiffs as the case progresses, amid ongoing concerns over NIH’s future leadership and funding policies, as reported by Forbes.
